Questioning the preclinical paradigm: natural, extreme biology as an alternative discovery platform - Test2 - elhamkhani - TriplyDB

Questioning the preclinical paradigm: natural, extreme biology as an alternative discovery platform

Questioning the preclinical paradigm: natural, extreme biology as an alternative discovery platform

http://www.wikidata.org/entity/Q28085421

about

Unraveling the message: insights into comparative genomics of the naked mole-rat Mouse models of human disease: An evolutionary perspective Regulation of Nrf2 signaling and longevity in naturally long-lived rodents.Mechanisms of oxidative stress resistance in the brain: Lessons learned from hypoxia tolerant extremophilic vertebrates.Seasonal and post-trauma remodeling in cone-dominant ground squirrel retina.Modeling human disease in rodents by CRISPR/Cas9 genome editing.Solving the Neurogenesis Puzzle: Looking for Pieces Outside the Traditional Box.Metabolic clues to salubrious longevity in the brain of the longest-lived rodent: the naked mole-rat.

P2860

Q26745908-F6DD4F3A-3A88-4ED3-8BA1-556E757BF36D Q28602393-7D215B1F-23C5-4785-937E-C39B5FACD361 Q35229453-D307ADE0-2934-4EDA-9B9F-6C545B765881 Q38405132-71301B54-D0B3-4CC9-ADA5-A02A80AE09C0 Q38710907-4E6C867D-AEA5-40AC-8886-2C945DD8A791 Q39414403-BBDB3C3E-5556-4091-A8E8-AB82322B90C0 Q41699670-749BFE56-6E5A-45D8-9413-30B5170A2488 Q46733752-5D1328B4-7194-4950-A131-92C93AF1AD37

P2860

Questioning the preclinical paradigm: natural, extreme biology as an alternative discovery platform

http://www.wikidata.org/entity/Q28085421

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Questioning the preclinical pa ...... alternative discovery platform

@ast

Questioning the preclinical pa ...... alternative discovery platform

@en

Questioning the preclinical pa ...... alternative discovery platform

@nl

type

label

Questioning the preclinical pa ...... alternative discovery platform

@ast

Questioning the preclinical pa ...... alternative discovery platform

@en

Questioning the preclinical pa ...... alternative discovery platform

@nl

prefLabel

Questioning the preclinical pa ...... alternative discovery platform

@ast

Questioning the preclinical pa ...... alternative discovery platform

@en

Questioning the preclinical pa ...... alternative discovery platform

@nl

P1433

Q28085421-8D33073B-919B-429C-AD3F-C26FB9582F1E

P1476

Q28085421-06C865F5-591B-461A-9742-BE8F57891471

P2093

Q28085421-21F3DF16-D60A-41F6-B271-2899A62323FB

Q28085421-829A336C-A697-4D68-9923-23AE35414F13

Q28085421-847320B6-8AA3-4539-8EB8-099E9FF57FA1

P275

Q28085421-565C9CA2-EEC0-4F86-9AFF-46B962DF93FA

P2860

Q28085421-026D91FC-9A5F-4B3C-B7C4-FACDC5AD8DD3

Q28085421-0649C444-2AF8-4FF2-9B11-B96E922B6B10

Q28085421-070D4EF5-EC26-4E66-8612-325B4D515E3C

Q28085421-078B9337-8754-4551-B3CE-795A445F67C5

Q28085421-0BF4F8A2-96C9-4D2C-87E9-A788335A85AB

Q28085421-0C5CCB67-A132-4F2B-A719-A23A5D199FC5

Q28085421-11D9BAAC-592B-4542-A2D1-3D23E019A3FA

Q28085421-11EEA9B0-3F8B-43CF-B20E-D81D4A0F2E2D

Q28085421-15D7E99B-D809-4710-8817-A4CD99114F75

Q28085421-17A69D08-E038-4EDA-92EA-5DD6EC286FBB

P304

Q28085421-8F48FDA3-1A3C-4235-B099-AE64B236F0A3

P31

Q28085421-55203FBE-BA8C-487D-8750-3649D20197B7

Q28085421-88393051-37B7-45C9-B9C9-73E1DC5A6121

P3181

Q28085421-68123A49-CEFD-4287-8D48-019719BE52DE

P356

Q28085421-E6D90598-958C-4301-99A8-700EDADC2BAE

P407

Q28085421-17661AE9-1102-411A-9296-260A1B289953

P433

Q28085421-58B34EB2-F72D-40F4-B16A-77FA27A4D2D0

P478

Q28085421-CBBCC207-DAC8-4327-B69F-274F4B107B81

P577

Q28085421-32D41132-D3EA-4E67-B299-DDBA776B137A

Q28085421-7A9D1924-81DA-4FAB-B022-E97C18C860CC

P698

Q28085421-E172C311-3CDF-486D-A6E1-877CE2437C61

P921

Q28085421-86C21840-E41C-4577-B4B8-79E113548741

P932

Q28085421-6C0856B3-D5DC-4E92-A77D-D128F0BBF145

P3181

P356

P1433

P1476

Questioning the preclinical pa ...... alternative discovery platform

@en

P2093

Kevin C. Corbit

http://www.w3.org/2001/XMLSchema#string

O. Lynne Nelson

http://www.w3.org/2001/XMLSchema#string

Rochelle Buffenstein

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

RNA sequencing reveals differential expression of mitochondrial and oxidation reduction genes in the long-lived naked mole-rat when compared to mice

Diet and cancer

Drug development: Raise standards for preclinical cancer research

FGF-21 as a novel metabolic regulator.

Cancer and ageing in mice and men

"Control" laboratory rodents are metabolically morbid: why it matters

Genome sequencing reveals insights into physiology and longevity of the naked mole rat

An analysis of the relationship between metabolism, developmental schedules, and longevity using phylogenetic independent contrasts

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion

A C. elegans mutant that lives twice as long as wild type

P304

913-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

362876

http://www.w3.org/2001/XMLSchema#string

P356

10.18632/AGING.100704

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25553771

http://www.w3.org/2001/XMLSchema#string

P921

biomedical investigative technique

P932

4276785

http://www.w3.org/2001/XMLSchema#string